Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Mahindra Manulife Business Cycle Fund · Direct ✕HDFC Pharma and Healthcare Fund · Direct ✕

Growth of ₹10,000

Basics

Mahindra Manulife Business Cycle FundHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseMahindra ManulifeHDFC
NAV₹16.4191₹23.6750
NAV date20 Nov 202620 Nov 2026
History3.2 years3.1 years
Expense ratio1.0%1.1%
Stars★★★★★★★★★★
Growth Score59.3094.50

Returns

Mahindra Manulife Business Cycle FundHDFC Pharma and Healthcare Fund
1 month+6.27%+12.97%
3 months−1.87%+7.13%
6 months+3.28%+17.84%
YTD+2.49%+33.73%
1 year+3.03%+32.20%
3 years (CAGR)+17.05%+30.70%
5 years (CAGR)——
10 years (CAGR)——
Since launch+16.75%+31.83%

Risk

Mahindra Manulife Business Cycle FundHDFC Pharma and Healthcare Fund
Volatility17.2%15.8%
Downside volatility10.8%8.5%
Sharpe0.611.53
Sortino0.982.86
Calmar0.802.06
Return / risk0.991.95
Deepest fall−21.44%−14.91%
Days to recover476126
Below its high−2.48%+0.00%

Against benchmark

Mahindra Manulife Business Cycle FundHDFC Pharma and Healthcare Fund
Alpha+4.65%+7.54%
Beta1.020.97
R²90.5%85.0%
Up capture118.9%108.9%
Down capture101.9%71.0%
Tracking error5.3%6.1%
Information ratio0.901.17
Treynor0.090.24

Consistency

Mahindra Manulife Business Cycle FundHDFC Pharma and Healthcare Fund
Best 1-year+64.33%+67.01%
Middle 1-year+8.13%+23.25%
Worst 1-year−8.62%+1.71%
1-year periods with a loss14.3%0.0%
Middle 3-year+16.49%+30.22%
Positive months69.4%72.2%
Best day+3.70%+3.18%
Worst day−7.82%−3.61%
Worst 5% day−1.64%−1.51%
Positive days58.0%58.3%
NAVs a year247247

SIP of ₹10,000 a month

Mahindra Manulife Business Cycle FundHDFC Pharma and Healthcare Fund
5-year XIRR——
5-year value——
3-year XIRR+8.30%+27.71%
1-year XIRR+5.13%+41.37%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth